D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$9.6B |
| 2 |
Amazon
AMZN
|
+$1.56B |
| 3 |
NVIDIA
NVDA
|
+$1.1B |
| 4 |
Meta Platforms (Facebook)
META
|
+$924M |
| 5 |
SpaceX
SPCX
|
+$907M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$2.17B |
| 2 |
Broadcom
AVGO
|
+$1.53B |
| 3 |
Microsoft
MSFT
|
+$1.05B |
| 4 |
TSMC
TSM
|
+$928M |
| 5 |
Texas Instruments
TXN
|
+$904M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 33.7% |
| 2 | Technology | 18.77% |
| 3 | Financials | 8.35% |
| 4 | Healthcare | 7.91% |
| 5 | Consumer Discretionary | 7.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1701
MBX Biosciences
MBX
$2.32B
| $10.1M | ﹤0.01% |
182,767
-106,122
| -37% | -$3.71M |
2025 Q4
2 quarters
|
|
1702
Griffon
GFF
$4.4B
| $10.1M | ﹤0.01% |
103,229
-152,387
| -60% | -$13.3M |
2023 Q3
11 quarters
|
|
1703
PUT
Argan
AGX
$4.63B
| $10.1M | ﹤0.01% |
12,600
+6,400
| +103% | +$4.26M |
2025 Q1
5 quarters
|
|
1704
Carlyle Group
CG
$13.7B
| $10.1M | ﹤0.01% |
238,883
+221,354
| +1,263% | +$10.4M |
2025 Q3
3 quarters
|
|
1705
CALL
Whirlpool
WHR
$1.83B
| $10.1M | ﹤0.01% |
255,000
-27,800
| -10% | -$1.3M |
2018 Q2
32 quarters
|
|
1706
Nucor
NUE
$59.1B
| $10M | ﹤0.01% |
44,983
+34,595
| +333% | +$7.83M |
2025 Q4
2 quarters
|
|
1707
Axiom Intelligence Acquisition Corp 1
AXIN
$283M
| $10M | ﹤0.01% |
968,981
+100
| +0% | +$1.03K |
2025 Q3
3 quarters
|
|
1708
Vermilion Energy
VET
$2.14B
| $10M | ﹤0.01% |
1,070,934
-68,300
| -6% | -$812K |
2024 Q4
6 quarters
|
|
1709
Ellington Financial
EFC
$1.5B
| $10M | ﹤0.01% |
735,331
+197,821
| +37% | +$2.62M |
2025 Q3
3 quarters
|
|
1710
PUT
Wheaton Precious Metals
WPM
$55.1B
| $10M | ﹤0.01% |
+89,100
| New | +$11.6M |
2026 Q2
0 quarters
|
|
1711
PUT
Blackrock
BLK
$172B
| $10M | ﹤0.01% |
+10,400
| New | +$10.8M |
2026 Q2
0 quarters
|
|
1712
PUT
Ares Management
ARES
$27.9B
| $10M | ﹤0.01% |
89,600
+4,600
| +5% | +$552K |
2026 Q1
1 quarter
|
|
1713
ATN International
ATNI
$397M
| $9.9M | ﹤0.01% |
375,137
+1,566
| +0.4% | +$42.6K |
2016 Q2
40 quarters
|
|
1714
Jumia Technologies
JMIA
$772M
| $9.9M | ﹤0.01% |
1,408,044
-1,606,353
| -53% | -$11.4M |
2020 Q3
23 quarters
|
|
1715
CALL
Krystal Biotech
KRYS
$9.31B
| $9.9M | ﹤0.01% |
26,700
+17,300
| +184% | +$5.17M |
2026 Q1
1 quarter
|
|
1716
CALL
TC Energy
TRP
$64.9B
| $9.9M | ﹤0.01% |
150,000
| – | – |
2026 Q1
1 quarter
|
|
1717
Idacorp
IDA
$8.13B
| $9.9M | ﹤0.01% |
65,573
+32,946
| +101% | +$4.74M |
2025 Q3
3 quarters
|
|
1718
Telus
TU
$13.8B
| $9.9M | ﹤0.01% |
937,906
-916,532
| -49% | -$11.2M |
2023 Q2
12 quarters
|
|
1719
X3 Acquisition Corp
XCBE
| $9.9M | ﹤0.01% |
990,000
+340,000
| +52% | +$3.37M |
2026 Q1
1 quarter
|
|
1720
VeriSign
VRSN
$27.7B
| $9.9M | ﹤0.01% |
39,260
+3,695
| +10% | +$1.03M |
2013 Q2
52 quarters
|
|
1721
Artivion
AORT
$1.12B
| $9.8M | ﹤0.01% |
438,216
+431,690
| +6,615% | +$12.1M |
2025 Q4
2 quarters
|
|
1722
CALL
Abbott
ABT
$179B
| $9.8M | ﹤0.01% |
108,500
+5,000
| +5% | +$456K |
2024 Q4
6 quarters
|
|
1723
Brink's
BCO
$4.67B
| $9.8M | ﹤0.01% |
104,066
+67,314
| +183% | +$7.01M |
2025 Q1
5 quarters
|
|
|
HVII
1724
DELISTED
Hennessy Capital Investment Corp VII
HVII
| $9.8M | ﹤0.01% |
940,500
| – | – |
2025 Q1
5 quarters
|
|
1725
CALL
Williams Companies
WMB
$87.9B
| $9.8M | ﹤0.01% |
+131,900
| New | +$9.7M |
2026 Q2
0 quarters
|
|
Similar funds
D.E. Shaw & Co's Q2 2026 Portfolio in Review
As of Q2 2026, D.E. Shaw & Co held 5,360 positions worth $210B, up 26% from $166B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
D.E. Shaw & Co deployed $8.31B of net new capital in Q2 2026, opening 872 new positions and adding to 1,718 existing holdings. Its largest new stake was SpaceX: 5,340,000 shares worth $912M.
By sector, the portfolio is most concentrated in Miscellaneous at 34% of assets, up from 30% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Micron Technology, an estimated $2.17B trimmed.
- D.E. Shaw & Co's largest Q2 2026 buy was SpaceX: 5,340,000 shares worth $912M.
- D.E. Shaw & Co added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $9.6B increase.
- D.E. Shaw & Co's biggest Q2 2026 reduction was Micron Technology, cutting an estimated $2.17B.
- D.E. Shaw & Co fully exited Automatic Data Processing in Q2 2026, selling an estimated $241M.
- D.E. Shaw & Co's ten largest holdings make up 15% of its $210B portfolio in Q2 2026.
- D.E. Shaw & Co opened 872 new positions and closed 527 in Q2 2026.
- D.E. Shaw & Co's portfolio value rose 26% quarter-over-quarter to $210B.
Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.